tm
Seeing Is Believing
tm
Seeing Is Believing
NMTC is currently covered by 3 analysts
Neuroone Medical Technologies Corp's activity chart (see below) currently has 9 price targets and 14 ratings on display. The stock rating distribution of NMTC is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 41.67% with an average time for these price targets to be met of 565 days.
Most recent stock forecast was given by from LAKE STREET on 15-Aug-2023. First documented stock forecast 15-Nov-2021.
Currently out of the existing stock ratings of NMTC, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Dec-2021
$2.2
$-1.14 (-34.13%)
3 years 2 months 5 days ago
(15-Aug-2023)
1/3 (33.33%)
$1.15 (109.52%)
975
Buy Since 15-Nov-2021
$2
4 years 6 months 21 days ago
(29-Mar-2022)
1/2 (50%)
$0.82 (69.49%)
155
What is NMTC (Neuroone Medical Technologies Corp) average time for price targets to be met?
Which analyst most recently updated their price target on NMTC (Neuroone Medical Technologies Corp)?
Which analyst has the current lower performing score on NMTC (Neuroone Medical Technologies Corp) with a proven track record?
Which analyst has the most public recommendations on NMTC (Neuroone Medical Technologies Corp)?
Which analyst is the currently most bullish on NMTC (Neuroone Medical Technologies Corp)?
Which analyst is the currently most reserved on NMTC (Neuroone Medical Technologies Corp)?
